Health Care

Shares of Tekmira Pharmaceuticals soared Monday after the Canadian drugmaker said it would buy privately held OnCore Biopharma to form a team focused on developing a hepatitis B cure.

Pharmaceutical distributor AmerisourceBergen is spending about $2.5 billion to expand its reach into veterinary medicine with the purchase of MWI Veterinary Supply.

Shares of Cempra shot up nearly 30 percent early Monday after the antibiotic developer said its treatment for patients with a common form of pneumonia fared well in late-stage clinical testing.

Shares of ImmunoGen plunged 37 percent in premarket trading Friday after a breast cancer treatment from drug development partner Roche failed to deliver significant improvement in a key late-stage study measurement of cancer patients.

Mallinckrodt will re-evaluate its fiscal 2015 forecast after the Food and Drug Administration said it is concerned that the company's generic ADHD drug is not equivalent to the brand-name drug it is based on.

For stocks, it's just what the doctor ordered.

Sanofi's net profit slipped 2.4 percent in the third quarter as the maker of the Lantus diabetes treatment booked a higher charge for restructuring at its French operations.

Shares of medical equipment maker Becton, Dickinson and Co. and rival CareFusion both bounced above their 52-week highs Monday before markets opened and a day after the companies announced their $12.2 billion combination.

Shares of companies that are studying potential vaccines for Ebola climbed after federal officials announced that the first case of the disease has been diagnosed in the U.S.

Shares of Exelixis jumped Monday before markets opened and after the drugmaker said its treatment for a deadly form of skin cancer fared better than another drug in a late-stage clinical study.

Shares of Intercept Pharmaceuticals Inc. soared in premarket trading Tuesday, a day after the drug developer said its most advanced candidate performed better than a placebo in a mid-stage study of patients with a form of chronic liver disease.

When swings in the stock market cause anxiety to spike, like it is now, many investors aim to get healthy.

A year after Americans recoiled at new revelations that sick veterans were getting sicker while languishing on waiting lists — and months after the Department of Veterans Affairs instituted major reforms costing billions of dollars — government data shows that the number of patients facing long waits at VA facilities has not dropped at all.

The hospital where a man diagnosed with Ebola died and two nurses were infected with the virus says its revenue and patient roles have plummeted.

As a group, biotech companies were among the best performers in what was a stellar year for US stocks: The group was up 66%, outpacing the broader market by a staggering 3600 basis points.  

Few places illustrate the growing gap separating the rich from everyone else as starkly as the Hamptons, the summer playground for the have and have-mores.

Vanguard founder Jack Bogle told FBN’s Maria Bartiromo that Wal-Mart’s decision to cut health insurance benefits for some part-time workers could have long-lasting negative effects on the company.

Making the case for more M&A in 2016.

Fraud allegations rock Valeant Pharmaceuticals.

Opko Health's finance head, Juan Rodriguez, will step down to pursue other business interests but will continue to provide services in a consulting capacity.